Adding liraglutide to the backbone therapy of biguanide in patients with coronary artery disease and newly diagnosed type-2 diabetes.
Phase of Trial: Phase IV
Latest Information Update: 01 Dec 2017
At a glance
- Drugs Liraglutide (Primary) ; Metformin
- Indications Coronary artery disease; Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Acronyms AddHope2
- 10 Jun 2017 Biomarkers information updated
- 19 Oct 2016 Results assessing the effect of liraglutide on heart rate and heart rate variability over 12 weeks published in the Diabetes Care.
- 21 Feb 2015 Status changed from recruiting to completed as reported by European Clinical Trials Database.